Malignant hypertension is characterized by a severe rise in the blood pressure which cannot then be lowered. It is diagnosed by the presence of advanced retinopathy in the presence of a diastolic blood pressure of over 120 mm Hg.
Malignant hypertension is more common in people of an African decent and also more common in smokers. It affects about 1% of people already suffering with high blood pressure. It is also been known to occur children, and in women join pregnancy.
When malignant hypertension occurs, there is usually a characteristic rush or increase in the blood pressure often for no apparent reason. Because it is very difficult to reduce malignant blood pressure, it can and will cause the vital organs of the body irreversible damage. The organs are all put under tremendous pressure. This can include damage to the brain, eyes, heart, kidneys and blood vessels.
Those suffering from malignant hypertension may also complain of
• Confusion • Decreased urinary output • Headaches • Vomiting • Abnormal sensations to the arms, legs and other areas. • Some visual disturbances. • Change in their mental state • Restlessness and anxiety • Decreased alertness and ability to think and concentrate • Extreme fatigue • Chest pain • Shortness of breath and cough
The prognosis of people suffering from malignant hypertension can be bleak, as the damage caused to the body is often life threatening especially to older people suffering from malignant hypertension.
Any treatment given to a person suffering with malignant hypertension, should be given carefully as a sudden decrease in the blood pressure from very high levels can be just as dangerous as a blood pressure kept at a consistently high level. Malignant blood pressure should be decreased gradually over a period of at least a week. Complete bed rest is also often prescribed to ensure no addition stress is placed on the body.
If it is treated promptly, malignant hypertension can be controlled without any further complications. However the person suffering with malignant hypertension should be monitored very carefully.
Selengkapnya...
IP
Malignant Hypertension Explained
Posted by Admin at 1:50 AM 0 comments
Malignant Mesothelioma Information
Malignant mesothelioma is a type of cancer that is quite rare; it affects only the thin wall of cells that line the internal organs and structures. This lining is called the mesothelium and malignant mesothelioma can manifest itself in three main ways. It can be pleural which affects the lungs, peritoneal which affects the abdominal cavity wall and pericardial which affects the lining in the heart. Experts believe that there is only one way to contract malignant mesothelioma and that is through exposure to asbestos.
Asbestos is a naturally occurring mineral that is highly toxic to humans yet was once used in abundance in the building and construction trades. It was used as it has a very high tolerance of heat and it is remarkably strong, it was also very cheap. It is made of fibres which are microscopic and can be airborne when ceilings covered with asbestos crack or when it is otherwise exposed to the air. When fibres of asbestos get inside the body they cannot be broken down or expelled and this will result in serious scarring of the mesothelioma and inflammation. Once this scarring occurs it is only a matter of time before malignant mesothelioma takes hold in one of its various forms.
Symptoms of malignant mesothelioma can initially be quite hard to spot as they can be quite unnoticeable. As a result they can be passed off as being day to day illnesses and this can cause even more problems as this delay gives malignant mesothelioma even more time to take hold of a person. It has been known for people with malignant mesothelioma to live with their symptoms for up to six months before they seek medical help with them. Symptoms of the various forms of malignant mesothelioma can include – shortness of breath, weight loss, nausea, vomiting, persistent coughing with or without blood in it, abdominal pains, stomach pains, chest pains, pain in the lower back and in some cases swelling of the face and arms and a loss of sensory capabilities. As these symptoms are so wide ranging and often seemingly unconnected it is no wonder that it can be difficult to obtain a correct diagnosis. Experts now recommend that anyone who has had prior exposure to asbestos at some point in their lives gets checked out for malignant mesothelioma even if they feel fit and well. Doing this could vastly extend a person’s life who could go on to be diagnosed with malignant mesothelioma.
Treatment for malignant mesothelioma can vary and surgery should only be an option if the disease is diagnosed in the very early stages. Otherwise it is more common for a person to undergo chemotherapy or radiotherapy to attempt to control the malignant mesothelioma. Although there is no known cure for malignant mesothelioma it can be controlled for some time if it is caught in time. Otherwise the outlook is not particularly positive and the best that many people with malignant mesothelioma can hope for is to be able to manage their symptoms and pain with painkillers and other medication.
Selengkapnya...
Posted by Admin at 1:49 AM 0 comments
Protection Insurance
Protection Insurance;It's tempting to sit back and relax once you've moved into your new home - but hang on, have you made sure that you're insured against all the risks that could stop you from paying your mortgage? Many things could go wrong and make it impossible for you to work, and in this article we go through each risk, and assess how important it is that you take that into account. If you are responsible for a family, then it is particularly important that you take heed of the following five issues:
What happens if interest rates increase and you can no longer afford your monthly repayments
What if you get made redundant
What happens if you become ill or have an accident and you can't go to work
What if you have a serious accident or become critically ill, and you can never go back to work
What if you die and your family is left to cope with the outstanding mortgage
These are all questions that new homeowners have to ask, and find answers to. The good news is, the insurance industry have it covered, and there are policies out there that can provide peace of mind against all these possibilities.
On the subject of rising interest rates, you are unfortunate if you end up in the position where you can't afford the repayments, because there are mortgages that help protect you from this. The fixed rate mortgage sets a rate for an agreed period of time in which your interest rate remains the same irrespective of the Bank of England base rate. A capped mortgage allows your payments to fluctuate, but there will be an agreed rate at which the interest rate that you pay will be capped. Capped mortgages protect you for an average of 3-5 years, and then, as with the fixed rate mortgage, it will revert to the standard variable rate.
55% of all new mortgages are fixed rate deals, so they are by far the most popular type of mortgage. The capped mortgage is less popular because it still retains an element of risk, and they can be more expensive at the outset, which deters a lot of potential customers. At the end of the protected period, for both types of mortgage, you can choose to re-mortgage with another company without paying any penalties. It's a good idea to keep your eye on the available offers as the end of the protected period approaches, because there are likely to better deals out there. The market is so competitive that new offers are always arising, and they are particularly focused on attracting re-mortgaging customers. Ask a mortgage broker to see what else is out there, as they have all the latest information to hand. You don't have to commit yourself to anything.
If you want to insure yourself against the possibility of losing your job, then you need Mortgage Payment Protection Insurance. However it's important to be aware that this type of insurance is designed to protect those that are made redundant, not those that resign or are dismissed. We found quotes on the Internet for around £2.45 per £100 of monthly mortgage payment. Once you stop working, the insurance will start paying after 30 days and then for a maximum of 12 months. You can buy this insurance through your mortgage lender but we don't recommend it, they always charge more than their internet rivals.
You also have the choice of covering your mortgage payments due to sickness or illness keeping you from working. However we recommend checking with your employer first to see if they have a sickness payment plan in place. Some companies will give their employees full pay for six months for accident or illness. Even in this case, it's still worth getting the insurance because you could be off work for more than six months. It would be very difficult to meet the mortgage repayments on statutory sickness benefits alone. This type of insurance also costs £2.45 per £100 of monthly mortgage payment, but you can combine it with unemployment cover and it's £3.95 per month, which is less than buying the two separately. Both will cover you for a maximum of 12 months, so you really need to consider what would happen if a serious accident or illness left you permanently unable to work.
The insurance industry estimates that 1/5 of men and 1/6 of women have to permanently leave work before retirement age because of a serious illness or accident. Think about it, if you have a heart attack at the age of 45 then you are unlikely to go back to work again. With a family to support, this could be disastrous.
In this case, then you would need Critical illness insurance - it covers the outstanding mortgage in full if you are unable to work again. Look out for "total and permanent disability" cover - it is essential that it is included in the policy as it specifically covers the possibility of you not working again due to accident.
There are a few options to look out for with Critical Illness Insurance - for example you need "decreasing cover" if you have a repayment mortgage. This is so the value of the payout decreases in line with the value of your outstanding mortgage. It is also cheaper than the alternative: "level cover". You need this if you have an interest only mortgage because the outstanding mortgage balance will remain the same.
Make sure you know all the facts about the insurance you buy, because there will be times that you can't make a claim. For example, Critical illness Insurance requires you to survive for a period following an accident or diagnosis of a critical illness, usually 28 days but sometimes 14 days. If you die before that time, then no claim can be made on your policy.
To cover the possibility of you dying within 28 days, then you need mortgage life insurance. Many lenders require you to set up a mortgage life insurance policy as a condition of you taking out the mortgage. You don't have to buy it through the lender however, in fact it will be a lot cheaper if you don't. Also if you live alone and do not have to support a family, you don't necessarily need this type of insurance as the lender will recoup the money for the outstanding mortgage by selling off the property.
Mortgage Life insurance is the most popular kind of mortgage protection, and like critical illness insurance, you can choose between "decreasing cover" and "level cover" depending on whether you have a repayment or an interest only mortgage.
There's no denying that buying all these insurance policies to protect your mortgage will cost, but there are a few ways to get the best value. Firstly, if you combine accident and illness with unemployment cover then you will save around 20%, compared to buying them separately. Some insurance companies may refer to this as "unemployment and disability" cover. Critical illness and mortgage life insurance also become cheaper if you combine the two, and we predict an average saving of 20-25%.
And don't forget the most obvious way to save money - shop around. Your lender will quote you on these insurances, and may even give you the impression that you have to buy your insurance through them, but you are free to buy it from any company you please. So it had might as well be the cheapest! Go online for the best deals, even better - contact a specialist life insurance broker and ask them to find the best deals for you. They can do all the legwork and, if you're not impressed, then you don't have to buy through them. The advantage they have on price is due to the hot competition on the Internet, especially for insurance. Brokers offer better deals by slashing their commission and giving you a further discount. Search using any of the following terms: "cheap life insurance", "life insurance", "life insurance quotes" or "Mortgage Protection Insurance", and you will come across a number of cost-effective options.
The other advantage to using a broker is that you have full access to their expert advice. When faced with the option of getting a "Guaranteed Premium" or a "Reviewable Premium" for your critical illness insurance, will you know what it means? Even if you do, which one is best? That's when a life insurance adviser is worth their weight in gold. So we recommend picking up the phone and talking to an expert in person, it doesn't take long and it guarantees you getting it right first time.
The bottom line: peace of mind comes at a price - but it doesn't have to be expensive!
Selengkapnya...
Posted by Admin at 7:37 PM 0 comments
The Cancer Market Outlook To 2014
In the current decade, oncology has been one of the most important growth segments among the pharmaceutical markets with a major focus on targeted agents (drug treatments developed to preferentially target those signaling pathways that are disregulated in tumors). Most innovation in oncology over the past 10 years has been driven by scientific advances, particularly in genomics, transcriptomics and proteomics.
In the current decade, oncology has been one of the most important growth segments among the pharmaceutical markets with a major focus on targeted agents (drug treatments developed to preferentially target those signaling pathways that are disregulated in tumors). Most innovation in oncology over the past 10 years has been driven by scientific advances, particularly in genomics, transcriptomics and proteomics.
In the current environment, the successful oncology players of the future will be those that can anticipate protocol evolution and design the most relevant clinical trials. In recent years, biotech companies have fuelled innovation in oncology more than ever before. Partnering with biotech companies is a key (but expensive) source of innovation for many pharma companies as approximately 75% of phase II, III and pre-registration innovative drugs are of biotech origin.
At $47.7bn, cancer is one of the largest, fastest growing markets in the pharmaceutical industry. However, pricing risk remains the key investment concern in oncology. The key concern, however, is not price erosion driven by competitive forces, but price cuts imposed by payors irrespective of the fact that such unilateral price cuts by payors have never occurred in any of the major developed markets and would surely jeopardize the premise on which the entire biopharmaceutical industry has been built.
Key features of this report
* Epidemiological analysis and forecast prevalence of the major cancer indications over the period 2008-14 including lung, breast, colorectal, ovarian cancer markets.
* Forecasts and analysis of the major products in the cancer market over the period 2008-14 spread across the major indications and classes of treatments.
* Overview of key events in the global cancer market that have impacted treatment trends and sales potential across the major cancer indications.
* Strategic and growth analysis of leading pharmaceutical corporations based on sales focus by drug class, currently marketed products and R&D product portfolios.
Scope of this report
* Develop insight into patient potential with the report's coverage of major indications in the cancer segment, the seven largest geographic pharmaceutical markets and 10 largest companies active in the cancer segment today
* Quickly understand how recent events are affecting the performance of major products, and how their marketers are confronting competitive changes in cancer marketplace
* Gain up-to-date competitive intelligence across the cancer indications and understand the major issues affecting key pharmaceutical/biotech players
* Understand which indications have the greatest potential to provide franchise growth, and how pharmaceutical companies are attempting to exploit these opportunities
Key Market Issues
* FDA approves Cervarix for cervical cancer In October 2009, FDA approved GSK's Cervarix for the prevention of pre-cancerous lesions caused by human papillomavirus (HPV) type 16 & 18 in women aged 10-25 years. Cervarix's inclusion in children's vaccine program is a major step towards securing reimbursement. Cervarix, expected to launch by the end of 2009, faces direct competition from Merck's Gardasil and will help to reduce the incidence of cervical cancer in future.
* Merck's Gardasil adds US indication of genital warts for boys and men On 16th October 2009, Gardasil's US label was extended to include its use in both men and boys aged 9-26 years of age. The pivotal trial results showed an efficacy of 90.4% while preventing external genital lesions of HPV types 6/11/16/18. In addition, Merck also planned to extend its vaccine patient assistance program providing free Gardasil to 19-26 year old uninsured males meeting eligibility criteria but unable to afford the vaccine.
Key findings from this report
* In 2008, antineoplastic mAbs delivered huge sales of $13.6bn with a market share of 28.6% of total sales. The key antineoplastic mAbs which contributed to the higher market share of this class in 2008 were MabThera (11.0%), Avastin (10.3%), Herceptin (9.7%) and Erbitux (3.4%). Forecast sales of the total antineoplastics market are estimated at $65.2bn in 2014.
* Roche is the global market leader in cancer, holding the highest market share of 29.2% ($14.0bn sales) in 2008 based on sales from (MabThera, Avastin, Herceptin, Tarceva and Xeloda). Roche's strength in the cancer market has been bolstered by its acquisition of Genentech and purchase of majority stakes in Chugai, which has provided additional breadth to its portfolio.
* Eli Lilly's acquisition of ImClone will increase the former's flow of high-quality, innovative new therapies. The transaction will immediately enable Eli Lilly to offer physicians and their patients a complementary portfolio of leading oncolytic agents and targeted therapies including Gemzar, Alimta and Erbitux.
Key questions answered
* What will be the major growth indications in the cancer segment over the period 2008-14?
* Which companies were the winners and losers in the cancer segment in 2008?
* How have recent major launches from companies such as Roche, Sanofi-Aventis, AstraZeneca, Novartis and Eli Lilly performed? * Which companies will become the key players in the cancer segment over the period 2008-14?
* Which products will be impacted by generic competitors over the period 2008-14?
Table of Contents: The Cancer Market Outlook to 2014
Executive Summary 12
Epidemiology of Cancer 12
Global Market Analysis 13
Pipeline Analysis 14
Competitive Landscape 15
Chapter 1 Scope and methodology 18
Scope 18
Methodology 19
Chapter 2 Overview and epidemiology of cancer indications 22
Summary 22
Introduction 23
Overview 23
Cancer risk factors 23
Lung cancer 24
Overview 24
Diagnosis, treatment and management 25
Epidemiology 27
NSCLC 27
SCLC 28
Forecast epidemiology 29
NSCLC 29
SCLC 30
Colorectal cancer 31
Overview 31
Diagnosis, treatment and management 31
Epidemiology 32
Forecast epidemiology 33
Breast cancer 34
Overview 34
Diagnosis, treatment and management 35
Epidemiology 36
Forecast epidemiology 37
Ovarian cancer 38
Overview 38
Diagnosis, treatment and management 39
Epidemiology 40
Forecast epidemiology 41
Uterine and cervical cancer 42
Overview 42
Diagnosis, treatment and management 43
Epidemiology 44
Forecast epidemiology 44
Leukemia 45
Overview 45
Diagnosis, treatment and management 47
Epidemiology 48
Forecast epidemiology 48
Prostate cancer 49
Overview 49
Diagnosis, treatment and management 50
Epidemiology 51
Forecast epidemiology 51
Pancreatic cancer 53
Overview 53
Diagnosis, treatment and management 53
Epidemiology 54
Forecast epidemiology 54
Lymphomas 56
Overview 56
Diagnosis, treatment and management 56
Epidemiology 57
Forecast epidemiology 58
Head and neck cancer 60
Overview 60
Diagnosis, treatment and management 61
Epidemiology 62
Forecast epidemiology 62
Chapter 3 Global market analysis 66
Summary 66
Introduction 67
Market analysis by country 67
Market analysis by drug class 69
Leading brand dynamics 70
MabThera (rituximab) -Roche/Genentech 71
Avastin (bevacizumab) - Roche/Genentech 73
Herceptin (trastuzumab) - Roche/Genentech/Chugai 74
Glivec/Gleevec (imatinib) - Novartis 75
Taxotere (docetaxel) - Sanofi-Aventis 76
Leading brands by type of cancer 77
Key recent events in the cancer market 80
FDA approves Cervarix for cervical cancer 80
Merck's Gardasil adds US indication of genital warts for boys and men 80
Roche's Avastin is filed for first-line breast cancer in Japan 80
Eisai to file first in-house breast cancer drug in major markets 81
Novartis's Tasigna bolsters its CML franchise 81
Antineoplastics 82
Competitive dynamics of antineoplastics 82
Leading brands of antineoplastics 84
Antineoplastic mAb market analysis 86
Market dynamics 86
Key brands analysis 86
Antineoplastic protein kinase inhibitors 88
Market dynamics 88
Key brands analysis 89
Vinca alkaloid market analysis 89
Market dynamics 89
Key brands analysis 90
Anti-metabolites 90
Market dynamics 90
Key brands analysis 90
Platinum compounds 92
Market dynamics 92
Key brands analysis 92
Antineoplastic sales forecast 93
Cytostatic hormonal therapies 94
Competitive dynamics of cytostatic hormonal therapies 94
Leading brands of cytostatic hormonal therapies 95
Cytostatic gonad hormone analog market analysis 97
Market dynamics 97
Key brands analysis 97
Aromatase inhibitors 98
Market dynamics 98
Key brands analysis 99
Anti-androgens 101
Market dynamics 101
Key brand analysis 102
Cytostatic hormonal therapy sales forecast 103
Global cancer market sales forecast 104
Chapter 4 Pipeline analysis 106
Summary 106
Introduction 107
Key trends in R&D 107
Targeted therapies are changing the treatment regimen of cancer 107
Biomarkers are personalizing oncology treatment 108
Cancer vaccines enhance the body's immune response 109
Pricing is becoming a major issue for cancer patients 109
Combination treatments are becoming the treatment of choice 110
Leading drugs in development 111
Phase III and pending approval compounds 112
Enzastaurin - Eli Lilly 112
BiovaxID - Biovest International and Accentia Biopharmaceuticals 115
Recentin (cediranib) - AstraZeneca 117
Zactima (vandetanib) - AstraZeneca 120
Axitinib (AG-13736) - Pfizer 124
Provenge (sipuleucel-T) - Dendreon 126
Recently approved/marketed drugs 127
Arzerra (ofatumumab) - GSK/Genmab 127
Afinitor (everolimus) - Novartis 130
Iressa (gefitinib) - AstraZeneca 132
Tykerb/Tyverb (lapatinib) - GSK 133
Votrient (pazopanib) - GSK 137
Pipeline forecast of key compounds 139
Factors affecting forecasts 139
Chapter 5 Competitive landscape 142
Summary 142
Introduction 143
Sales performance of leading players 143
Roche 146
Sales focus by drug class 146
Regional sales distribution 147
Marketed product portfolio 148
Pipeline analysis 150
Strategic and growth analysis 151
Drivers of growth 151
Resistors of growth 152
Sanofi-Aventis 153
Sales focus by drug class 153
Regional sales distribution 154
Marketed product portfolio 155
Pipeline analysis 156
Strategic and growth analysis 157
Drivers of growth 157
Resistors of growth 158
AstraZeneca 159
Sales focus by drug class 159
Regional sales distribution 160
Marketed product portfolio 161
Pipeline analysis 162
Strategic and growth analysis 163
Drivers of growth 163
Resistors of growth 163
Novartis 164
Sales focus by drug class 164
Regional sales distribution 165
Marketed product portfolio 166
Pipeline analysis 167
Strategic and growth analysis 168
Drivers of growth 168
Resistors of growth 168
Eli Lilly 169
Sales focus by drug class 169
Regional sales distribution 169
Marketed product portfolio 170
Pipeline analysis 171
Strategic and growth analysis 171
Drivers of growth 171
Resistors of growth 172
Pfizer 173
Sales focus by drug class 173
Regional sales distribution 174
Marketed product portfolio 175
Pipeline analysis 176
Strategic and growth analysis 177
Drivers of growth 177
Resistors of growth 177
Takeda 177
Sales focus by drug class 178
Regional sales distribution 179
Marketed product portfolio 179
Pipeline analysis 180
Strategic and growth analysis 181
Drivers of growth 181
Resistors of growth 181
Bristol-Myers Squibb 182
Sales focus by drug class 182
Regional sales distribution 183
Marketed product portfolio 184
Pipeline analysis 185
Strategic and growth analysis 186
Drivers of growth 186
Resistors of growth 186
Chapter 6 Appendix 188
IMS Data 188
Antineoplastic and immunomodulating agents 188
L1: Antineoplastics 188
L2: Cytostatic hormone therapy 188
Forecast factors 188
Glossary 189
Abbreviations used in this report 189
Index 191
Selengkapnya...
Posted by Admin at 7:36 PM 0 comments
Asbestos
Asbestos removal companies is going to vary widely in value and quality so it pays to do a tiny analysis before main which single to hire. Asbestos is a toxic and possibly deadly mineral found naturally everyone around the world. On average we breathe approximately 10,000 fibers of it each one day, nevertheless thankfully that's not enough to produce any apparent health difficulties. However, inhaling asbestos fibers in larger amounts and over longer durations of time can lead to lung cancer, asbestosis (chronic lung disease), and mesothelioma (cancerous tumor of the mesothelial tissue lining the lungs, abdominal cavity, and other internal organs).
Asbestos removal companies is going to vary widely in value and quality so it pays to do a tiny analysis before main which single to hire. Asbestos is a toxic and possibly deadly mineral found naturally everyone around the world. On average we breathe approximately 10,000 fibers of it each one day, nevertheless thankfully that's not enough to produce any apparent health difficulties. However, inhaling asbestos fibers in larger amounts and over longer durations of time can lead to lung cancer, asbestosis (chronic lung disease), and mesothelioma (cancerous tumor of the mesothelial tissue lining the lungs, abdominal cavity, and other internal organs).
Researchers have not settled on a safe level of contact with asbestos. Nonetheless, scientists and doctors suffer concluded that the larger and longer the contact with asbestos, the greater the chance of experiencing asbestos-connected ailments.
There also are a couple of different techniques to address and remove asbestos from your home. Sealing or asbestos encapsulation is where undamaged asbestos is coated with a substance that prevents the asbestos fibers from becoming airborne. If the asbestos is not intact and is crumbling or damaged then it must be covered or remove. It is very significant to seek the assist of a professional in this matter.
It is important that setups educate their employees on asbestos related issues on their premises. However; the most suitable option might be to remove asbestos from the premises by a trained professional. Difficulties associated with asbestos are not recognized until a colleague or a family member is diagnosed with difficulties related to asbestos take no risk and build your health a priority, purchase rid of asbestos now.
Atlanta asbestos lawyers lodge lawsuits of personal injury when victims bring mesothelioma lawsuits on his or her own behalf following having been diagnosed. It's very the asbestos lawyer who determines whether the employment records reflect any verified asbestos exposure period. Atlanta Asbestos lawyers obtain the verdict based on corporate provider, environmental records, and a victim's health.
When contracting with asbestos removal corporations be sure you buy everything in writing. This is the most effective path you will be in a position to protect yourself during the event of a disagreement or discrepancy. Pay half or fewer of the absolute value up front because this will assist you remain somewhat in control. The most effective way that some contractors may fulfill all of his or her obligations is if you actually retain a certain quantity of control. Any problems of security that may come up during the removal procedure is going to be more easily solved when you have not yet paid the full cost.
Selengkapnya...
Posted by Admin at 8:58 PM 0 comments
Mesothelioma Exposure
Mesothelioma cancer is often found among individuals who have been exposed to asbestos. Asbestos is a naturally-occurring fiber found in the altered industries. This material is useful in certain respects but are extremely harmful to the health of individuals to a great extent. During the mining and manufacturing of the fibers they may become dislodged from the mineral which often gets attached to the clothing or hair of anyone in the surrounding. Over time, the workers inhale the asbestos and this may lead to the development of cancer in such individual.
Mesothelioma cancer is often found among individuals who have been exposed to asbestos. Asbestos is a naturally-occurring fiber found in the altered industries. This material is useful in certain respects but are extremely harmful to the health of individuals to a great extent. During the mining and manufacturing of the fibers they may become dislodged from the mineral which often gets attached to the clothing or hair of anyone in the surrounding. Over time, the workers inhale the asbestos and this may lead to the development of cancer in such individual.
The magnitude of asbestos inhalation plays a big aspect in the spread of the cancer. This disease is also referred to as asbestos lung cancer. At times, an exposure to asbestos for only one or two months can result in Mesothelioma. The may fibers may have reached the lungs and quickly begin to develop in mesotheilum. They eventually move to the lower portion of the lungs and infect the lining. However, the cancer does not usually occur until 30-40 years after the exposure to asbestos as it is during this time that the asbestos spreads and reacts in the body. In some cases, the malignant cancer may not occur until after 70 years after being exposed to Asbestos.
The disease mesotheiloma generally occurs to persons who are in there 40's. However, due to the suttleness of the diesease only few cases of Mesothelioma have been diagnosed and recorded. It is highly advised that persons who are and have been exposed to asbestos take proper precautions in order to prevent the occurrence of this disease and also to check regularly with their doctor in order to have an early detecttion incase the disease develops.
An early detection, can prevent the spread of the disease and increase your chances of survival. Mesothelioma is generally develops in the right or the left side of the pleura and at times may also infect the diaphragm. This stage is the first development of the disease. In stage 2, the disease begins to invade the walls of the chest. At point, it can affect the esophagus, heart or even the pleura on both the sides. In stage 3, the Mesothelioma cancer penetrates through the diaphragm and reaches the abdominal cavity and in the final stage it spreads into the blood streams and the other organs of the body.
Statistics have shown that the disease Mesothelioma occurs more in men than in women. Most forms of Mesothelioma cancer is considered to be very fatal. The rates of survival Mesothelioma victims are very rare, however if early treatment takes place, then the patient may be blessed with a longer survival span.
To Learn More About Mesothelioma and How You Can Be A Part of The Cure Visit Mesothelioma Help Today
Selengkapnya...
Posted by Admin at 8:57 PM 0 comments
About Mesothelioma
Have you ever heard of mesothelioma? If you are not aware of what exactly is mesothelioma, in this article we will tell you about this type of disease. Basically this is a rare kind of cancer which generally arises from the cells lining the sacs of the chest or the abdomen.
There are two major cell types of mesothelioma. These are the epithelial and the sarcomatoid. In some cases there is only one type of cell while in the other there can be combination of both the types of cells. The occurrence of sarcomatoid is rare. In some cases, the mesothelioma can also occur from benign and the non-malignant cells. However, this type of mesothelioma cancer can be treated surgically.
Use and distribution of this article is subject to our Publisher Guidelines
whereby the original author's information and copyright must be included.
Know More About Mesothelioma by Terro White
in Health / Cancer (submitted 2010-04-05)
Have you ever heard of mesothelioma? If you are not aware of what exactly is mesothelioma, in this article we will tell you about this type of disease. Basically this is a rare kind of cancer which generally arises from the cells lining the sacs of the chest or the abdomen.
There are two major cell types of mesothelioma. These are the epithelial and the sarcomatoid. In some cases there is only one type of cell while in the other there can be combination of both the types of cells. The occurrence of sarcomatoid is rare. In some cases, the mesothelioma can also occur from benign and the non-malignant cells. However, this type of mesothelioma cancer can be treated surgically.
There are several symptoms associated with the occurrence of mesothelioma. In some cases the patient suffering from this disease can complain from the chest pain and the shortness of breath. At times, though the pleura are associated with this type of cancer, yet there is no pleuritic pain. This results in the late diagnosis and consequently late treatment. Unfortunately in some cases, the mesothelioma cancer does not show any kind of symptoms at all. In such cases, it becomes very difficult for the patient to survive longer.
As the disease reaches its advanced stage, the patient suffers from the loss of weight due to the loss of appetite. This is also associated with extreme pain in the abdomen or the chest. The breathing problem gets increased resulting in extreme discomfort of the patient. Some patients suffering from mesothelioma in its early stage also complains of the developing night sweats. The diaphragm stops functioning and there arises several complicated in the body one by one.
The tests involved in the disease may include a CT Scan or a biopsy. There are several treatment options of this disease. It can be treated with surgery, radiation therapy, chemo therapy or in some cases with drugs. The kind of treatment to be done depends on the extent of the spread of the cancer and the ability of the patient to accept the treatment.
As technology is getting more progressed, research is being conducted to improve the treatment procedures of Mesothelioma. Some doctors in the recent days combine one treatment options with the other. This may include the combination of chemo therapy with other kind of therapy or it may also involve chemo therapy with some particular kind of drug. In the recent days, research is also being conducted on the processes of biological therapy.
In some cases, alternative treatment options are also available which may include acupuncture, massage therapy but these are not so effective always.
About the Author
If you want further information about Mesothelioma, you should log on to mesotheliomahelp.net. This site would give you ample information about Mesothelioma cancer, its symptoms and the treatment options available. Therefore without any delay, you must log on to this site and get all the necessary information that you might require.
Selengkapnya...
Posted by Admin at 8:55 PM 0 comments
